13.75 +0.52 (3.98%)
EURX
Stock Details
Last Trade:13.75 Change:+0.52 (3.98%) Prev Close:13.23 Open: 13.05 Days Range:13.02 – 13.86 52 Week Range: 6.17 - 19.60 Volume:21148 P/E: N/AEPS:0.00
View AllRecent Alerts 07/04/09
Recent Alert on 06/25/09 at 8:49am
Oppenheimer Initiates Coverage on Eurand (EURX)
Oppenheimer Initiates Coverage on Eurand (EURX)
Oppenheimer initiates coverage on Eurand (Nasdaq: EURX) with an Outperform. Price target $16. To see more analyst ratings on EURX Click Here. Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company.
Recent Alert on 06/22/09 at 8:25am
FDA Advises Eurand (EURX) That It Has Extended the Review Period for ZENPEP(TM) Therapy
FDA Advises Eurand (EURX) That It Has Extended the Review Period for ZENPEP(TM) Therapy
Recent Alert on 06/22/09 at 8:25am
FDA Advises Eurand (EURX) That It Has Extended the Review Period for ZENPEP(TM) Therapy
FDA Advises Eurand (EURX) That It Has Extended the Review Period for ZENPEP(TM) Therapy
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/13/08 at 6:15pm
Market highlights for next week: Lehman Brothers and Morgan Stanley reporting earnings
Market highlights for next week: Lehman Brothers and Morgan Stanley reporting earnings